A Message From a Co-Chair
Balazs Halmos, MD
Last June, at the inaugural International Congress on Oncology Pathology™, I was awestruck by the dedication to patient care and eagerness to learn of all who attended. It’s rare that a specialized educational conference like this exists to bring together multiple healthcare professionals, across specialties and disciplines.
In 2017 we started on the path Towards the Harmonization of Pathology and Oncology; now in 2018, we must take another step forward.
No two cancers are the same—no two patients. To provide the best possible care for every patient, the collaboration of pathologists and oncologists is indispensable. More than the diagnosis of patients, coordination between team members is vital in determining the course of treatment, monitoring patients, succeeding in surgery, and formulating new ways to approach the way we treat cancer.
This year, at our 2nd Annual meeting, keynote lectures will cover the role of liquid biopsies in the management of our patients, the latest data on driver mutations and pan tumor predictive biomarkers, and methods to address variations in care across the United States. Whether you treat breast cancers, gastrointestinal cancers, hematologic malignancies, gynecologic or genitourinary disease, or lung cancers—whether you’re involved in the management of all of the above—this congress is designed to address challenges you face in clinic.
In a field as fast-paced as oncology, continually learning, integrating what we’ve learned, and rising to meet new challenges is a skill we’ve honed over years of practice. In our journey to ever improve patient care, we are not alone. The International Congress on Oncology Pathology™ is here to help us reach that goal. The next generation of cancer care is here, join us in New York and we’ll meet it together!
Balazs Halmos, MD